ArticleHuman vaccines & immunotherapeutics2026
An exploratory study to determine the feasibility and processes needed to implement the Immunization Neighborhood to increase HPV vaccination among African American adolescents and adolescents in the general population: A multi-partner perspective.
Article in Human vaccines & immunotherapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Limited education and healthcare access are major contributors to Human Papillomavirus (HPV) vaccination disparities among African American adolescents. The Immunization Neighborhood (IN) involves enhanced communication and collaboration among providers to address people's needs by expanding access points and education to increase vaccination. Because needs of immunization providers and parents to effectively collaborate are unknown, this study explored the feasibility of and processes needed for IN utilization across key partners: pediatricians, pharmacists, school nurses, health department staff, and African American parent-child dyads. We conducted a semi-structured interviews in a qualitative, descriptive study with a purposive sample of 30 African American parent-child dyads and 37 immunization providers in Middle Tennessee. The Consolidated Framework for Implementation Research (CFIR) guided inductive-deductive thematic analysis. We identified facilitators and barriers to IN utilization for four CFIR domains: (1) Intervention characteristics; (2) Outer setting; (3) Inner setting; and (4) Individual characteristics. Across CFIR domains and partners, key perceived facilitators include convenience, accessibility, extended hours, partner coordination, and existing subsidized programs. Perceived barriers included fragmented vaccination tracking, limited vaccine registry interoperability, existing policies, and lack of knowledge and trust in immunization providers and settings. Our study highlights the need for multi-component, collaborative, and patient-centered strategies for IN implementation to improve adolescent HPV vaccination rates, especially among African American adolescents. Policy changes to reduce out-of-pocket expenses, increase insurance coverage, require reporting to state immunization registries, encourage collaborative practices, and allow HPV vaccine delivery in schools could potentially enhance IN impact.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.